Buy Call For SEQUENT -- Long Term Investment
Net profit of Sequent Scientific reported to Rs 8.27 crore in the quarter ended December 2023 as against net loss of Rs 8.87 crore during the previous quarter ended December 2022. Sales declined 12.24% to Rs 329.36 crore in the quarter ended December 2023 as against Rs 375.31 crore during the previous quarter ended December 2022.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.